Pathogenesis and management of autoimmune diseases of the skin.
D000962:Antimalarials / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy*; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000209:etiology*; D010392:Pemphigus / Q000188:drug therapy / Q000209:etiology*; D011241:Prednisone / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy / Q000276:immunology*; D014222:Triamcinolone Acetonide / Q000627:therapeutic use
D000962:Antimalarials; D007166:Immunosuppressive Agents; D005446:Fluocinolone Acetonide; D014222:Triamcinolone Acetonide; D011241:Prednisone